-+ 0.00%
-+ 0.00%
-+ 0.00%

Raymond James Initiates Coverage On Odyssey Therapeutics with Outperform Rating, Announces Price Target of $42

Benzinga·10/09/2026 11:01:21
Listen to the news
Raymond James analyst Thomas Deal initiates coverage on Odyssey Therapeutics (NASDAQ:ODTX) with a Outperform rating and announces Price Target of $42.